The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis

被引:2
作者
Quan, Liuliu [1 ,2 ]
Dai, Jiawen [3 ,4 ]
Luo, Yuan [5 ]
Wang, Lin [6 ]
Liu, Yue [5 ]
Meng, Jiaqi [5 ]
Yang, Fan [5 ]
You, Xin [2 ,7 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Shuaifuyuan 1, Beijing 100730, Peoples R China
[3] Tianjin Inst Hlth Sci, Tianjin, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst,, Tianjin, Peoples R China
[5] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
[6] Southwest Med Univ, Sch Clin Med, Luzhou, Peoples R China
[7] Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China
关键词
Systemic lupus erythematosus; citations; bibliometric analysis; literature review; bibliometrics; research hotspots; B-LYMPHOCYTE STIMULATOR; RECEPTOR MONOCLONAL-ANTIBODY; RHEUMATOLOGY DAMAGE INDEX; GENOME-WIDE ASSOCIATION; DISEASE-ACTIVITY INDEX; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE-DISEASES; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; ANTICARDIOLIPIN ANTIBODIES;
D O I
10.1080/21645515.2024.2387461
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Systemic lupus erythematosus (SLE) is an autoimmune inflammatory tissue disease. In view of the explosive growth in research on SLE, bibliometrics was performed to evaluate the 100 top-cited papers in this realm. We performed the search with terms "systemic lupus erythematosus" the Web of Science Core Collection database on May 3, 2023. Relevant literatures were screened. Data were extracted and analyzed by SPSS. The citations of 100 top-cited SLE studies spanned from 472 to 13,557. Most studies (60 out of 100) were conducted in the United States. Total citation times were positively associated with ACY, which was negatively correlated with the length of time since publication. Approximately half of the studies focused on the underlying mechanisms of SLE. New biologic therapies garnered attention and development. Our findings provide valuable insights into the developments in crucial areas of SLE and shed contributions to future studies.
引用
收藏
页数:16
相关论文
共 140 条
  • [1] Epidemiology, diagnosis, vaccines, and bibliometric analysis of the 100 top-cited studies on Hepatitis E virus
    Ahmad, Tauseef
    Nasir, Saima
    Musa, Taha Hussein
    AlRyalat, Saif Aldeen S.
    Khan, Muhammad
    Hui, Jin
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 857 - 871
  • [2] ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE ANALYSIS OF 500 CONSECUTIVE PATIENTS
    ALARCONSEGOVIA, D
    DELEZE, M
    ORIA, CV
    SANCHEZGUERRERO, J
    GOMEZPACHECO, L
    CABIEDES, J
    FERNANDEZ, L
    DELEON, SP
    [J]. MEDICINE, 1989, 68 (06) : 353 - 365
  • [3] EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
    Andreoli, L.
    Bertsias, G. K.
    Agmon-Levin, N.
    Brown, S.
    Cervera, R.
    Costedoat-Chalumeau, N.
    Doria, A.
    Fischer-Betz, R.
    Forger, F.
    Moraes-Fontes, M. F.
    Khamashta, M.
    King, J.
    Lojacono, A.
    Marchiori, F.
    Meroni, P. L.
    Mosca, M.
    Motta, M.
    Ostensen, M.
    Pamfil, C.
    Raio, L.
    Schneider, M.
    Svenungsson, E.
    Tektonidou, M.
    Yavuz, S.
    Boumpas, D.
    Tincani, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (03) : 476 - 485
  • [4] Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
    Appel, Gerald B.
    Contreras, Gabriel
    Dooley, Mary Anne
    Ginzler, Ellen M.
    Isenberg, David
    Jayne, David
    Li, Lei-Shi
    Mysler, Eduardo
    Sanchez-Guerrero, Jorge
    Solomons, Neil
    Wofsy, David
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (05): : 1103 - 1112
  • [5] Development of autoantibodies before the clinical onset of systemic lupus erythematosus
    Arbuckle, MR
    McClain, MT
    Rubertone, MV
    Scofield, RH
    Dennis, GJ
    James, JA
    Harley, JB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) : 1526 - 1533
  • [6] Aringer M., 2019, Ann Rheum Dis, V71, P166, DOI [10.1111/1756-185X.14269, DOI 10.1111/1756-185X.14269]
  • [7] Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
    Baechler, EC
    Batliwalla, FM
    Karypis, G
    Gaffney, PM
    Ortmann, WA
    Espe, KJ
    Shark, KB
    Grande, WJ
    Hughes, KM
    Kapur, V
    Gregersen, PK
    Behrens, TW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) : 2610 - 2615
  • [8] Type I interferon in systemic lupus erythematosus and other autoimmune diseases
    Banchereau, Jacques
    Pascual, Virginia
    [J]. IMMUNITY, 2006, 25 (03) : 383 - 392
  • [9] Global epidemiology of systemic lupus erythematosus
    Barber, Megan R. W.
    Drenkard, Cristina
    Falasinnu, Titilola
    Hoi, Alberta
    Mak, Anselm
    Kow, Nien Yee
    Svenungsson, Elisabet
    Peterson, Jonna
    Clarke, Ann E.
    Ramsey-Goldman, Rosalind
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (09) : 515 - 532
  • [10] Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus
    Barrat, FJ
    Meeker, T
    Gregorio, J
    Chan, JH
    Uematsu, S
    Akira, S
    Chang, B
    Duramad, O
    Coffman, RL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) : 1131 - 1139